HCPLive Year in Review: Top Podcasts & Shows for 2024
HCPLive
DECEMBER 26, 2024
From groundbreaking therapies to ethical dilemmas, HCPLives top podcasts of 2024 delivered expert insights and human stories across medicine.
Thu.Dec 26, 2024
89 
Less Sleep During and After Pregnancy May Spell Future Heart Troubles
Med Page Today
DECEMBER 26, 2024
(MedPage Today) -- Persistently short sleep duration during and after pregnancy was tied to a greater risk for adverse cardiometabolic outcomes, a secondary analysis of cohort study data showed. Women who said they slept fewer than 7 hours a night.
FDA Proposes Rule for Standardized Asbestos Testing in Talc-Containing Cosmetic Products
HCPLive
DECEMBER 26, 2024
The proposed rule seeks to establish and require standardized testing methods to detect and identify asbestos in cosmetic products with talc.
Cleveland Clinic touts at-home heart failure treatment: 6 takeaways
Becker's Hospital Review - Cardiology
DECEMBER 26, 2024
Some acute heart failure patients can be safely and successfully treated at home, according to a research letter published Nov. 16 in JACC: Heart Failure.
5 FDA Decisions to Watch in Q1 2025
HCPLive
DECEMBER 26, 2024
We spotlight 5 impactful regulatory decisions scheduled to occur during the first quarter of 2025.
Women are less likely than men to take medication after a stroke, study suggests
Medical Xpress - Cardiology
DECEMBER 26, 2024
Female stroke victims are less likely than men to take drugs that could lower their odds of a second stroke.
Cardiology Year in Review: 2024
HCPLive
DECEMBER 26, 2024
This listicle highlights 5 major approvals and 5 trial updates in cardiovascular care from 2024.
Sign up to get articles personalized to your interests!
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
More Trending
Wegovy : Where do we go & why do we go ?
Dr. S. Venkatesan MD
DECEMBER 26, 2024
Courresey : A news clip from The Guardian , UK 26th December2024. Can any one dare to stop this prescription medication with significant metabolic side effects ,being flashed in the Newyork bill board ? Semaglutide is a GLP 1 agonist, (Glucagon like peptide) primarily used in diabetes where it competes with glucagon and modulates its adverse action.
Operator Characteristics and Reintervention Following Pacemaker Implant – Insights From A National Database
HeartRhythm
DECEMBER 26, 2024
Some data suggest that operator procedure numbers and characteristics are associated with outcomes following cardiac device implantation. However, most of these data concern ICD implantation and are limited to in-hospital complications.1-3 The aim of this study was to evaluate whether operator characteristics were associated with reintervention rates following a first permanent pacemaker (PPM) implantation.
Let's personalize your content